OM:SOBIBiotechs
Swedish Orphan Biovitrum (OM:SOBI) Stock Faces Margin Compression As One Off Loss Clouds EPS
Swedish Orphan Biovitrum (OM:SOBI) has posted fresh Q2 2026 numbers, with revenue at SEK 7.8b and basic EPS of 3.17 SEK setting the tone for the latest update. Over recent quarters the company has seen revenue move from SEK 6.2b in Q2 2025 to SEK 7.8b in Q2 2026, while basic EPS shifted from 1.85 SEK to 3.17 SEK alongside a trailing twelve month net margin of 4.5% that contrasts with higher profitability a year earlier. This set of results puts the focus squarely on how margins are holding up...